MetLife Investment Management’s IBEX IBEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$191K Hold
6,305
﹤0.01% 2441
2026
Q1
$169K Hold
6,305
﹤0.01% 2308
2025
Q4
$241K Hold
6,305
﹤0.01% 2185
2025
Q3
$255K Buy
6,305
+1,149
+22% +$36.5K ﹤0.01% 2182
2025
Q2
$150K Buy
5,156
+154
+3% +$4.12K ﹤0.01% 2339
2025
Q1
$122K Sell
5,002
-259
-5% -$6.21K ﹤0.01% 2433
2024
Q4
$113K Hold
5,261
﹤0.01% 2569
2024
Q3
$105K Hold
5,261
﹤0.01% 2605
2024
Q2
$85.1K Buy
5,261
+555
+12% +$8.19K ﹤0.01% 2669
2024
Q1
$72.6K Hold
4,706
﹤0.01% 2660
2023
Q4
$89.5K Buy
+4,706
New +$81.8K ﹤0.01% 2652
2023
Q3
Sell
-4,706
Closed -$99.9K 2927
2023
Q2
$99.9K Hold
4,706
﹤0.01% 2682
2023
Q1
$115K Hold
4,706
﹤0.01% 2493
2022
Q4
$117K Buy
+4,706
New +$106K ﹤0.01% 2526

Other funds holding IBEX

MetLife Investment Management's IBEX Position: Q2 2026 in Review

MetLife Investment Management held its IBEX (IBEX) position steady in Q2 2026 at 6,305 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

MetLife Investment Management first reported a position in IBEX in Q4 2022 and has held it in 14 quarters since. The position peaked at $255K in Q3 2025. 153 funds tracked by Wall St. Rank hold IBEX as of Q2 2026.

  • MetLife Investment Management held 6,305 shares of IBEX worth $191K as of Q2 2026.
  • MetLife Investment Management left its IBEX share count unchanged in Q2 2026.
  • IBEX made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2441 holding.
  • MetLife Investment Management first reported a position in IBEX in Q4 2022 and has held it in 14 quarters since.
  • MetLife Investment Management's IBEX position peaked at $255K in Q3 2025.
  • 153 funds tracked by Wall St. Rank held IBEX as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.